The INN crowd.
出版信息
Nat Biotechnol. 2013 Dec;31(12):1055. doi: 10.1038/nbt.2760.
DOI:10.1038/nbt.2760
PMID:24316620
Abstract
摘要
相似文献
1
The INN crowd.
Nat Biotechnol. 2013 Dec;31(12):1055. doi: 10.1038/nbt.2760.
2
A divided INN crowd.
Nat Biotechnol. 2014 Feb;32(2):132. doi: 10.1038/nbt.2819.
3
A divided INN crowd.
Nat Biotechnol. 2014 Feb;32(2):131. doi: 10.1038/nbt.2817.
4
A divided INN crowd.
Nat Biotechnol. 2014 Feb;32(2):130. doi: 10.1038/nbt.2820.
5
A divided INN crowd.
Nat Biotechnol. 2014 Feb;32(2):131-2. doi: 10.1038/nbt.2818.
6
Nature Biotechnology responds.
Nat Biotechnol. 2014 Feb;32(2):132. doi: 10.1038/nbt.2822.
7
What's in a drug name?
J Am Pharm Assoc (2003). 2004 Jan-Feb;44(1):12-4. doi: 10.1331/154434504322713174.
8
[Generic prescription should be evaluated as new way of prescription in Denmark].[通用处方应作为丹麦新的处方方式进行评估]
Ugeskr Laeger. 2012 Aug 27;174(35):1974.
9
New countermeasures considered as drug counterfeiting grows.随着药品造假现象增多，新的应对措施被提上日程。
Nat Med. 2008 Jul;14(7):700. doi: 10.1038/nm0708-700a.
10
Use caution when donating drugs, guidelines suggest.指南建议，捐赠药品时需谨慎。
CMAJ. 1990 Jan 1;142(1):65-6.
引用本文的文献
1
Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.利妥昔单抗的过去、现在与未来——全球首个肿瘤学单克隆抗体疗法
Front Oncol. 2018 Jun 4;8:163. doi: 10.3389/fonc.2018.00163. eCollection 2018.
2
Biosimilars in rheumatology: current perspectives and lessons learnt.风湿病学中的生物类似药：当前的观点和经验教训。
Nat Rev Rheumatol. 2015 Dec;11(12):713-24. doi: 10.1038/nrrheum.2015.110. Epub 2015 Aug 18.
3
Biosimilars: The naming puzzle.生物类似药：命名难题。
Indian J Pharmacol. 2015 May-Jun;47(3):339. doi: 10.4103/0253-7613.157140.
4
A divided INN crowd.
Nat Biotechnol. 2014 Feb;32(2):132. doi: 10.1038/nbt.2819.
5
A divided INN crowd.
Nat Biotechnol. 2014 Feb;32(2):131. doi: 10.1038/nbt.2817.
6
A divided INN crowd.
Nat Biotechnol. 2014 Feb;32(2):131-2. doi: 10.1038/nbt.2818.
7
A divided INN crowd.
Nat Biotechnol. 2014 Feb;32(2):130. doi: 10.1038/nbt.2820.
Zotero 插件